Sumitomo Dainippon Pharma (Japan)
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
1.9K
Total Open
Publications
814
Total
Citations
57K
Open Access
Percentage
42%
Total
Publications
1.9K
Total Open
Publications
814
Total
Citations
57K
Breakdown
Publisher Open
23%
Both
16%
Other Platform Open
3%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
285
Hybrid 20%
156
No Guarantees 42%
317
Other Platform Open
Domain 83%
307
Other Internet 18%
66
Institution 14%
50
Public 2%
8
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 306 |
DOI | Other Internet | 56 |
Europe PMC | Domain | 22 |
Unknown Repository | Other Internet | 12 |
Kyoto University - Kyoto University Research Information Repository | Institution | 10 |
Hokkaido University - Hokkaido University Collection of Scholarly and Academic Papers | Institution | 7 |
Figshare | Public | 7 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
Nagasaki University - Nagasaki University's Academic Output SITE | Institution | 3 |